# Microflare Protocol in Poor Responders

> **NCT02185326** · PHASE4 · COMPLETED · sponsor: **Woman's Health University Hospital, Egypt** · enrollment: 145 (actual)

## Conditions studied

- Female Infertility Due to Diminished Ovarian Reserve

## Interventions

- **DRUG:** Growth hormone (Norditropin, Novo nordisk)

## Key facts

- **NCT ID:** NCT02185326
- **Lead sponsor:** Woman's Health University Hospital, Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2015-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02185326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02185326, "Microflare Protocol in Poor Responders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02185326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*